Anne Schaar, Ph.D. is a Senior Program Manager at Aldevron, a global leader in genomic medicine including the first mRNA-based personalized CRISPR therapy. In her role, Anne combines her scientific expertise with strategic leadership to ensure a client’s biologic product meets regulatory, quality, and delivery requirements at all stages of lifecycle. She earned her doctorate in Biochemistry and Molecular Biology from the University of North Dakota and completed postdoctoral research at the University of Wisconsin–Madison, focusing on metabolic diseases in an aging model.

Beyond her professional role, Anne is passionate about helping people learn about science and developing critical thinking skills. She advocates for educational initiatives that empower individuals to understand the scientific process, ask thoughtful questions, and make informed decisions, skills that are essential for progress in biotechnology and society at large.